Basel Medical Group Ltd (BMGL) shareholders
BMGLNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends June 30
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Oct 30, 2026Score 3/30
$0.32+0.02 (+7.34%)
Close on Nov 17, 2026Market cap $513.40KP/E –Yield –
Ownership
Who owns Basel Medical's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Rainforest Capital VCC Joint filing with Mengli Chen (54.20%), Keng Leong Fung (54.20%) | 10,174,579 | 54.20% | 13G (passive) | Feb 21, 2025 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Boon Chye Tan | Chief Commercial Officer, Director | 10,205,229 | 645.04% | Apr 14, 2026 |
| Alton Chun How Neo | Interim CFO | – | – | Jul 22, 2026 |
| Jianing JN Lu | Chief Financial Officer | – | – | Apr 15, 2026 |
| Darren Yen Feng Chhoa | Chief Executive Officer | – | – | Apr 14, 2026 |
| Xinwen Yang | Director | – | – | Oct 21, 2026 |
| Frederick Shieh Ming Hong | Director | – | – | Oct 1, 2026 |
| Kwek Yoon Soong | Director | – | – | Apr 21, 2026 |
| Keng Leong Fung | Director | 10,205,229 | 645.04% | Apr 14, 2026 |
| Tony Chen | Director | – | – | Apr 14, 2026 |
| Paul D. Freudenthaler | Director | – | – | Mar 4, 2026 |
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 1M shares a day
Change since last report
+731.6%
From 0M shares
Short volume, 20 days
53.5%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Basel Medical's stock actually held short. Settlement fails (shares not delivered on time) peaked at 34,939 shares on Sep 16, 2026 over the last 90 days.
See a number that looks wrong?